Perceptions of Equipoise, Risk–Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry
Karine Dubé(University of California System), Stuart Rennie(University of North Carolina at Chapel Hill), Amy Corneli(Clinical Research Institute), Brandon Brown(University of California, Riverside), Lynda Dee(AIDS United), Veronica Miller(University of California, Berkeley), Joseph D. Tucker(University of North Carolina Health Care), Laurie Sylla(Ministerio de Defensa), David Evans(Advisory Board Company (United States)), Asheley Cockrell Skinner(University of North Carolina at Chapel Hill), Sandra B. Greene(University of North Carolina at Chapel Hill), Jeff Taylor(University of North Carolina at Chapel Hill)
Cited by 40
Related Papers
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206
Team Structure and Culture Are Associated With Lower Burnout in Primary Care
|The Journal of the American Board of Family Medicine|2014|202
Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum
|Clinical Infectious Diseases|2024|145
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
|Current Opinion in HIV and AIDS|2014|116